Journal
RSC CHEMICAL BIOLOGY
Volume 2, Issue 2, Pages 368-386Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0cb00218f
Keywords
-
Funding
- University of Lodz, Poland
Ask authors/readers for more resources
Research has shown the potential of metal organometallic-derived antibacterial drugs and metal materials in the field of antimicrobials. By modifying existing antibacterial drugs with metal organometallic compounds and developing metal materials with antibacterial properties, drug resistance in bacteria can be overcome. Advances in the use of metal-based nanomaterials in medical devices and environmental pollution control have also been reported.
Rising bacterial antibiotic resistance is a global threat. To deal with it, new antibacterial agents and antiseptic materials need to be developed. One alternative in this quest is the organometallic derivatization of well-established antibacterial drugs and also the fabrication of advanced metal-based materials having antibacterial properties. Metal-based agents and materials often show new modes of antimicrobial action which enable them to overcome drug resistance in pathogenic bacterial strains. This review summarizes recent (2017-2020) progress in the field of organometallic-derived antibacterial drugs and metal-based materials having antibacterial activity. Specifically, it covers organometallic derivatives of antibacterial drugs including beta-lactams, ciprofloxacin, isoniazid, trimethoprim, sulfadoxine, sulfamethoxazole, and ethambutol as well as non-antibacterial drugs like metformin, phenformin and aspirin. Recent advances and reported clinical trials in the use of metal-based nanomaterials as antibiofouling coatings on medical devices, as photocatalytic agents in indoor air pollutant control, and also as photodynamic/photothermal antimicrobial agents are also summarized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available